Position in RXRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,084,796
-$1,146,082 QoQ
Shares Held
1,330,553
+4.0% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. RXRX ranks #114 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in RXRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,084,796 | 1,330,553 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,230,878 | 1,278,944 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,047,734 | 419,618 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $2,021,482 | 399,503 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,328,931 | 818,324 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $7,146,446 | 1,057,167 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $7,751,096 | 1,176,191 | Shares | Other | 2024-12-26 | |
| 2024-06-30 | $8,315,451 | 1,108,727 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $10,788,584 | 1,082,105 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $3,754,785 | 380,810 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $7,304,974 | 954,899 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $2,800,209 | 374,861 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $2,064,455 | 309,514 | Shares | Other | 2023-05-18 | |
| 2022-12-31 | $1,336,416 | 173,336 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $1,927,306 | 181,138 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $1,378,506 | 169,350 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $909,596 | 127,039 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $2,679,626 | 156,429 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $727,182 | 31,603 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $729,707 | 19,992 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||